Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
View ORCID ProfileRiffat Mehboob, View ORCID ProfileFridoon Jawad Ahmad, Ahad Qayyum, View ORCID ProfileMuhammad Asim Rana, View ORCID ProfileSyed Amir Gilani, Muhammad Akram Tariq, Gibran Ali, View ORCID ProfileShehla Javed Akram, Javed Akram
doi: https://doi.org/10.1101/2020.08.01.20166678
Riffat Mehboob
1Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Ph.DFridoon Jawad Ahmad
2Deparmtnet of Physiology, University of Health Sciences, Lahore, Pakistan
Ph.DAhad Qayyum
3Bahria International Hospital, Lahore, Pakistan
MDMuhammad Asim Rana
3Bahria International Hospital, Lahore, Pakistan
MDSyed Amir Gilani
1Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
MBBS, Ph.DMuhammad Akram Tariq
4Department of Biology, Postgraduate College, Township, Lahore, Pakistan
Ph.DGibran Ali
2Deparmtnet of Physiology, University of Health Sciences, Lahore, Pakistan
Ph.DShehla Javed Akram
5Akram Medical Complex, Lahore, Pakistan
MBBS, M.PhilJaved Akram
2Deparmtnet of Physiology, University of Health Sciences, Lahore, Pakistan
MBBS, FCPS, FRCSData Availability
Data will be made available on request
Posted December 17, 2020.
Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
Riffat Mehboob, Fridoon Jawad Ahmad, Ahad Qayyum, Muhammad Asim Rana, Syed Amir Gilani, Muhammad Akram Tariq, Gibran Ali, Shehla Javed Akram, Javed Akram
medRxiv 2020.08.01.20166678; doi: https://doi.org/10.1101/2020.08.01.20166678
Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
Riffat Mehboob, Fridoon Jawad Ahmad, Ahad Qayyum, Muhammad Asim Rana, Syed Amir Gilani, Muhammad Akram Tariq, Gibran Ali, Shehla Javed Akram, Javed Akram
medRxiv 2020.08.01.20166678; doi: https://doi.org/10.1101/2020.08.01.20166678
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2834)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12535)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2842)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1485)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)